The tumor suppressor KLF6 similarly generates an oncogenic splice variant, KLF6-SV1, which antagonizes wild-type KLF6, promoting tumor growth and leading to unfavorable clinical outcomes across multiple cancers [32]. This evidence concerns the gene KLF6 and cancer.